Epigenetic mechanisms underlying prostate cancer radioresistance

Radiotherapy (RT) is one of the mainstay treatments for prostate cancer (PCa), a highly prevalent neoplasm among males worldwide. About 30% of newly diagnosed PCa patients receive RT with a curative intent. However, biochemical relapse occurs in 20–40% of advanced PCa treated with RT either alone or...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo-Silva, Catarina, Benedetti, Rosaria, Ciardiello, Fortunato, Cappabianca, Salvatore, Jerónimo, Carmen, Altucci, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186094/
https://www.ncbi.nlm.nih.gov/pubmed/34103085
http://dx.doi.org/10.1186/s13148-021-01111-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186094/
https://www.ncbi.nlm.nih.gov/pubmed/34103085
http://dx.doi.org/10.1186/s13148-021-01111-8

Ejemplares similares